Webinar
From Clinical Data to Decisions: Integrating Clinical Pharmacology with Pharmacometrics Modelling

Watch insightful session on Clinical Pharmacology and Pharmacometrics Modelling. This webinar explores how Model-Informed Drug Development (MIDD) is transforming clinical and regulatory decisions through data-driven insights and real-world applications.

Understanding the connection between Clinical Pharmacology and Pharmacometrics Modelling is key to modern drug development.
In this session, you’ll discover how quantitative modeling methods, such as Model-Based Meta-Analysis (MBMA), rely on high-quality, standardized datasets to:

• Support confident dose selection
• Optimize clinical trial design
• Enhance regulatory strategy and decision-making

These strategies empower sponsors to make faster, evidence-based clinical decisions.

Through real-world case studies, Excelra’s Clinical Pharmacology team will demonstrate how analysis-ready datasets drive consistent and reproducible pharmacometric outcomes.

In this session, we will:

• Showcase how standardized data accelerates Model-Informed Drug Development (MIDD)
• Demonstrate real-world use cases for dose selection and regulatory discussions
• Highlight how data curation and visualization strengthen pharmacometric analysis
• Explore how integrating Clinical Pharmacology and Pharmacometrics Modelling creates a robust foundation for successful clinical programs

By attending, you’ll learn how Excelra’s expertise in data curation, visualization, and pharmacometric analysis helps organizations:

• Build stronger, model-informed strategies
• Optimize trial efficiency and reduce uncertainty
• Advance therapeutic innovation through data-driven insights